关于RNAi在NAFLD/NASH的治疗作用的最新情况
Hamideh Dehghan1, Alireza Ghasempour2, Mahboobeh Sabeti Akbar-Abad3
1Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Progress in molecular biology and translational science
|March 8, 2024
概括
治疗性寡核酸,如RNA干扰 (RNAi),在治疗非酒精性脂肪肝 (NAFLD) 和非酒精性脂肪肝 (NASH) 等代谢性肝病方面表现有前途,在缺乏药物的地方提供新的希望.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢性肝病,包括非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH),由于不健康的生活方式而增加.
- 肥胖是NAFLD的主要驱动因素,该疾病目前缺乏FDA批准的治疗方法.
- 治疗性寡核酸,特别是RNA干扰 (RNAi),为以前无法治疗的疾病提供了一种新的药物治疗方法.
研究的目的:
- 讨论RNA干扰 (RNAi) 在管理NAFLD等代谢性肝病中的潜在意义.
- 探索NAFLD/NASH作为治疗性寡核酸干预的目标的适用性.
- 提供对RNAi输送平台及其对NAFLD/NASH的治疗应用的见解.
主要方法:
- 文献综述和对目前关于RNA干扰 (RNAi) 技术的研究进行分析.
- 探索NAFLD/NASH病原体背后的机制.
- 检查现有和新兴的RNAi传递系统,这些系统与肝脏向疗法相关.
主要成果:
- RNA干扰 (RNAi) 对维持生理稳态和理解疾病发病有很大的潜力.
- 由于特定的分子途径,NAFLD/NASH为基于寡核酸的疗法提供了理想的标.
- 目前正在开发各种交付平台,以提高RNAi治疗肝脏疾病的疗效和安全性.
结论:
- RNA干扰 (RNAi) 是对代谢性肝病,包括NAFLD/NASH的有前途的治疗策略.
- 用寡核酸向NAFLD/NASH中的特定分子通路可能会导致有效的治疗方法.
- 在RNAi传递系统的进步对于实现治疗肝脏疾病的全部治疗潜力至关重要.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Small interfering RNAs (siRNA)
3.5K
3.5K


